On Tuesday, Shares of Royal Dutch Shell plc (ADR) (NYSE:RDS.A), gained 0.66% to $50.09.
Royal Dutch Shell plc’s, capital comprises of 3,941,881,005 A shares and 2,440,410,614 B shares, each with equal voting rights. Royal Dutch Shell plc holds no ordinary shares in Treasury.
The total number of A shares and B shares in issue is 6,382,291,619 and this figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Royal Dutch Shell plc under the FCA’s Disclosure and Transparency Rules.
Royal Dutch Shell plc operates as an independent oil and gas company worldwide. It operates through Upstream and Downstream segments. The company explores for and extracts crude oil, natural gas, and natural gas liquids.
Shares of Express Scripts Holding Company (NASDAQ:ESRX), inclined 1.57% to $86.82, during its last trading session.
Express Scripts, declared it will partner with Imprimis Pharmaceuticals (IMMY) to drive access to a low-cost alternative to Daraprim (pyrimethamine), a drug for the treatment of toxoplasmosis that has been recently priced out of reach for people with HIV, pregnant women and others with weakened immune systems.
Imprimis is offering a compounded oral formulation of pyrimethamine and leucovorin (a form of folic acid) for $1 per capsule for people whose pharmacy benefit is managed by Express Scripts. While the 62-year-old Daraprim was priced $13.50 per pill earlier this year, its owner, Turing Pharmaceuticals, made the decision in September to improvement the price to $750 per pill.
The companies expect that prescriptions for the pyrimethamine and leucovorin from Imprimis will be processed starting as early as this week for Express Scripts patients who need the treatment.
“Leveraging our expertise to improve access and affordability to an important medication is the right thing to do for HIV patients and others who could benefit from a combination of pyrimethamine and leucovorin,” said Dr. Steve Miller, Senior Vice President and Chief Medical Officer of Express Scripts. “We believe we now have an extremely cost-effective way to provide access to a Daraprim alternative. We will share our solution with other payers to make sure all appropriate patients around the country have access to the treatment they need at the lowest possible price.”
Express Scripts Holding Company operates as a pharmacy benefit administration (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations.
Finally, Shares of CONN’S, Inc. (NASDAQ:CONN), ended its last trade with -5.96% loss, and closed at $25.08.
Conn’s, declared it will host a conference call on December 8, 2015 to discuss its third-quarter fiscal 2016 financial results. The conference call will start at 10:00 A.M. CT (11:00 A.M. ET). A press release regarding the operating results will be released the same day before the market opens.
Conn’s, Inc. operates as a specialty retailer of durable consumer goods and related services in the United States. It operates through Retail and Credit segments. The company’s stores provide home appliance comprising refrigerators, freezers, washers, dryers, dishwashers, and ranges; home furniture and mattress, counting furniture and related accessories for the living room, dining room, and bedroom, in addition to traditional and specialty mattresses; and home office products comprising of computers, tablets, printers, and accessories.